Posaconazole
Top View
- Custom-Drug-List-Formulary.Pdf
- Guidelines for Treatment of Invasive Aspergillosis and Mucormycosis in Patients on Pediatric Services
- Drug-Drug Interaction Associated with Mold-Active Triazoles Among Hospitalized Patients
- Ranexa 375 Mg Prolonged-Release Tablets Ranexa 500 Mg Prolonged-Release Tablets Ranexa 750 Mg Prolonged-Release Tablets Ranolazine
- Your Prescription Benefit Updates
- Major Drug Interactions with Cyclosporine and Tacrolimus
- Posaconazole Versus Itraconazole As Prophylactic Antifungal Agents During Induction Chemotherapy for Acute Myeloid Leukemia: a Real-World Single Center Comparison
- To Prescribe the New Drug Flibanserin
- Supplemental Data for Drug Metabolism and Disposition
- Noxafil Oral Suspension 40 Mg Per Ml (3) These Highlights Do Not Include All the Information Needed to Use NOXAFIL Safely and Effectively
- Voriconazole More Likely Than Posaconazole Increases Plasma Exposure to Sublingual Buprenorphine Causing a Risk of a Clinically Important Interaction
- ANTIRETROVIRAL CONTRAINDICATIONS and DRUG INTERACTIONS (Part of 5)
- AHCCCS Pharmacy and Therapeutics Committee
- The Effect of Posaconazole, Itraconazole and Voriconazole In
- Fungal Infection Prevention After Hematopoietic Cell Transplantation
- Vilazodone: a New Treatment for Major Depressive Disorder
- Non-Invasive Management of Madura Foot with Oral Posaconazole and Ciprofloxacin
- ODEFSEY (Emtricitabine, Rilpivirine, and Tenofovir